Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)
Open Access
- 15 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 15 (1), 1-11
- https://doi.org/10.1186/s13023-020-01455-z
Abstract
International patient registries are of particular importance for rare disorders, as they may contribute to overcome the lack of knowledge derived from low number of patients and limited awareness of these diseases, and help to learn more about their geographical or population-based specificities, which is relevant for research purposes and for promoting better standards of care and diagnosis. Our objective was to create and implement a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC) and to disseminate the knowledge of these disorders. Teams from nine different countries (United Kingdom, Spain, Italy, France, Germany, Denmark, Greece, Turkey and USA) created a consortium that developed the first European registry dedicated to rare muscle glycogenoses. A work plan was implemented to design the database and platform that constitute the registry, by choosing clinical, genetics and molecular variables of interest, based on experience gained from previous national registries for similar metabolic disorders. Among dissemination activities, several teaching events were organized in different countries, especially those where the consortium considered the awareness of these diseases needs to be promoted among health professionals and patients. EUROMAC represents a step forward in the knowledge of those disorders to which it is dedicated, and will have relevant clinical outcomes at the diagnostic, epidemiological, clinical and research level.Keywords
Funding Information
- Consumers, Health and Food Executive Agency (2012-12-14)
- Instituto de Salud Carlos III (PI16/01492, PI19/01313)
- CIBERER (CIBERER-ACCI 2016-03)
This publication has 25 references indexed in Scilit:
- Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registryJournal of Neurology, Neurosurgery & Psychiatry, 2012
- McArdle disease: a clinical reviewJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Permanent muscle weakness in MCArdle diseaseMuscle & Nerve, 2009
- McArdle disease: what do neurologists need to know?Nature Clinical Practice Neurology, 2008
- Genotype modulators of clinical severity in McArdle diseaseNeuroscience Letters, 2007
- Favorable Responses to Acute and Chronic Exercise in McArdle PatientsClinical Journal of Sport Medicine, 2007
- Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: Identification of 10 new mutations. Absence of genotype–phenotype correlationNeuromuscular Disorders, 2007
- A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patientsHuman Mutation, 2007
- Exercise tolerance and daily life in McArdle's diseaseMuscle & Nerve, 2004
- Phenotype modulators in myophosphorylase deficiencyAnnals of Neurology, 2003